# Nab-Paclitaxel Plus Cisplatin With Concurrent Radiotherapy for Patients With Locally Advanced Cervical Cancer: A Multicentre, Single-arm, Phase II Trial.

> **NCT06426056** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Peking University Third Hospital** · enrollment: 64 (estimated)

## Conditions studied

- Cervical Cancer

## Interventions

- **RADIATION:** radiotherapy
- **DRUG:** Nab paclitaxel
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT06426056
- **Lead sponsor:** Peking University Third Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-06
- **Primary completion:** 2025-09
- **Final completion:** 2028-10
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2024-05-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06426056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06426056, "Nab-Paclitaxel Plus Cisplatin With Concurrent Radiotherapy for Patients With Locally Advanced Cervical Cancer: A Multicentre, Single-arm, Phase II Trial.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06426056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*